Some studies have compared VDZ and anti-TNF in elderly IBD patients with controversial results; two studies did not show differences in the incidence of significant infections or efficacy, but another showed a reduction in infection-related hospitalization with VDZ [98,99,100]. This evidence concerns the gene TNF and inflammatory bowel disease.